Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Twist Bioscience Corp (TWST)

NASDAQ
Currency in USD
50.30
+1.12(+2.28%)
Closed
After Hours
50.10-0.20(-0.40%)
TWST Scorecard
Full Analysis
Significant return over the last week
Fair Value
Day's Range
48.6550.42
52 wk Range
24.2560.90
Key Statistics
Edit
Prev. Close
49.18
Open
49.09
Day's Range
48.65-50.42
52 wk Range
24.25-60.9
Volume
739.45K
Average Volume (3m)
764.19K
1-Year Change
102.99%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TWST Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
50.49
Upside
+0.38%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile
Show more

Twist Bioscience Corp Company Profile

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Employees
923

Twist Bioscience Corp SWOT Analysis


DNA Innovator's Path
Explore Twist Bioscience's journey as a synthetic DNA pioneer, navigating projected losses while aiming for ambitious growth and margin targets
Market Dynamics
Delve into Twist's efforts to strengthen its position through improved account visibility and blanket orders, reshaping revenue predictability
Financial Outlook
Analysts project losses but anticipate 50% gross margins by 2025. Price targets range from $45 to $55, reflecting mixed market sentiment
Strategic Challenges
Learn how Twist balances R&D investments, market expansion, and operational efficiency in the competitive synthetic biology landscape
Read full SWOT analysis
TWST Full Pro Research
Institutional-Grade Stock Analysis
Understand how TWST earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Twist Bioscience Corp Earnings Call Summary for Q4/2024

  • Q4 revenue up 27% to $84.7M, annual revenue $330M (+28%); Q4 gross margin 45.1%, exceeding guidance
  • FY2025 revenue forecast $367M-$377M; SynBio growth 15-18%, NGS 20-24%; adjusted EBITDA loss to improve to $60M-$65M
  • Cash balance $276.4M, plus $15M from XOMA; aiming for 50% gross margin by Q4 FY2025 through efficiencies
  • Express product portfolio driving revenue and margin growth; customer base over 3,500; pushing towards adjusted EBITDA breakeven
  • Healthcare sector (60% of exposure) facing funding pressures; modest operational expense increases expected in FY2024
Last Updated: 11/19/2024, 03:30 PM
Read Full Transcript

Compare TWST to Peers and Sector

Metrics to compare
TWST
Peers
Sector
Relationship
P/E Ratio
−14.3x−5.2x−0.7x
PEG Ratio
-−0.090.00
Price/Book
6.3x2.3x2.6x
Price / LTM Sales
9.5x5.5x3.2x
Upside (Analyst Target)
6.8%70.1%43.2%
Fair Value Upside
Unlock13.4%6.8%Unlock

Analysts' Recommendations

8 Buy
2 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 50.49

(+0.38% Upside)

People Also Watch

28.30
BEAM
+3.40%
169.82
NTRA
+1.22%
340.59
APP
+1.14%

FAQ

What Is the Twist Bioscience (TWST) Stock Price Today?

The Twist Bioscience stock price today is 50.30

What Stock Exchange Does Twist Bioscience Trade On?

Twist Bioscience is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Twist Bioscience?

The stock symbol for Twist Bioscience is "TWST."

What Is the Twist Bioscience Market Cap?

As of today, Twist Bioscience market cap is 2.99B.

What is Twist Bioscience Earnings Per Share?

The Twist Bioscience EPS is -3.60.

What Is the Next Twist Bioscience Earnings Date?

Twist Bioscience will release its next earnings report on Jan 30, 2025.

From a Technical Analysis Perspective, Is TWST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.